Dublin - Research and Markets (http://www.researchandmarkets.com/research/c49e9a8e/pharmaceutical_h) has announced the addition of GlobalData's new report "Pharmaceutical & Healthcare Annual Deals Analysis 2012" to their offering.

Pharmaceutical & Healthcare Annual Deals Analysis 2012 report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on Partnerships, Licensing Agreements, M&As, Equity/Debt Offerings, Private Equity and Venture Financing transactions registered in the pharmaceutical and healthcare industry in Q4 2011. The report presents detailed comparative data on the number of deals and their value in the past five quarters categorized into deal types, segments, and geographies. Additionally, the report provides information on the top venture capital and advisory firms in the pharmaceutical and healthcare industry.

Deals And Value Of Deals Decline 19% And 14% In The Pharmaceutical and Healthcare Industry In 2011

The pharmaceutical and healthcare industry recorded a decline of 19% in deals and 14% in deal values, respectively in 2011 with the companies in the industry reducing their investments in R&D activities, decline in revenues from sales of drugs due to patent expiries, and growth in major market stalling. The industry recorded 4,032 deals worth $298.7 billion in 2011, as compared to 5,011 deals worth $346.9 billion in 2010. The oncology market recoded 848 deals and stood at the top in the pharmaceutical and healthcare industry in 2011.

Some of the high value deals in 2011 include, Medco Health Solutions, Inc., a provider of healthcare services, announcing acquisition of Express Scripts, a provider of pharmacy benefit management services, for a consideration of $29.1 billion; Takeda Pharmaceutical's acquisition of Nycomed International, a pharmaceutical company, for a purchase consideration of 9,600m ($13,681m) on a cash-free, debt-free basis; and Gilead Sciences' acquisition of Pharmasset, a clinical-stage pharmaceutical company, for a purchase consideration of $11,200m.

Key Topics Covered:

1 Table of contents

2 Pharmaceutical & Healthcare, Global, Deals Summary

3 Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2011

4 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type

5 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market

6 Pharmaceuticals & Healthcare, Deal Summary, By Geography

7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors

8 Further Information

For more information visit http://www.researchandmarkets.com/research/c49e9a8e/pharmaceutical_h

Source: GlobalData